Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No change of the lipid profile under the control of ApoE gene polymorphism in schizophrenics under paliperidone treatment.

The Psychiatric quarterly - 1 Dec 2014

Kao Wei-Tsung, Chang Chen-Lin, Chen Yi-Lung, Lung For-Wey

Abstract excerpt

The present study tried to explore the effects of Paliperidone on the lipid profiles of schizophrenia patients. One hundred twenty-nine subjects diagnosed with schizophrenia were enrolled into this study and completed the lipid profile evaluation. Their blood samples were obtained on the morning following a 12-hours fast. Cholesterol and triglyceride (TG) levels in plasma were determined, and lipoproteins were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Isoxazoles

Share to Lipids

Share to Psychiatric Status Rating Scales

Share to Pyrimidines

Share to Schizophrenia

Share to Surveys and Questionnaires

Source

Identifiers

PMID: 25085446
DOI: 10.1007/s11126-014-9309-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No change of the lipid profile under the control of ApoE gene polymorphism in schizophrenics under paliperidone treatment.PMID 25085446Read ↗

Low prevalence of lipid metabolism abnormalities in APOE ε2-genotype and male patients 60 years or older with schizophrenia.Semantic proximity Read ↗

Homozygosity in the APOE 3 Polymorphism Is Associated With Less Depression and Higher Serum Low-Density Lipoprotein in Chinese Elderly Schizophrenics.Semantic proximity Read ↗

Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's disease.Semantic proximity Read ↗

Association between lipid metabolism and cognitive function in patients with schizophreniaSemantic proximity Read ↗

The association of change in serum cholesterol levels and clinical treatment response in patients with schizophrenia: a prospective, randomized and open-label studySemantic proximity Read ↗

Long-term Metabolic Side Effects of Second-Generation Antipsychotics in Chinese Patients with Schizophrenia: A Within-Subject Approach with modelling of dosage effectsSemantic proximity Read ↗

Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort studySemantic proximity Read ↗

APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients.Semantic proximity Read ↗

Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels.Semantic proximity Read ↗

Iloperidone: A new drug for the treatment of schizophrenia.Semantic proximity Read ↗

Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.Semantic proximity Read ↗

TNF-α in schizophrenia: Associations with cholesterol and genetic variations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.